To evaluate the cellular functions of ANXA2, two stable ANXA2-specific knockdown cell lines were established after transduction of shRNA targeting ANXA2 into the TW01 and BM1 NPC cell lines. This evidence concerns the gene ANXA2 and nasopharyngeal carcinoma.